Carnosic acid enhances cisplatin sensitivity and suppresses gastric cancer progression via the TP53/SLC7A11/ALOX12 axis
Authors:
Open Access
- 23 July 2025
- journal article
- research article
- Published by Springer Nature in Hereditas
- Vol. 162 (1) , 1-10
Abstract
Background: Gastric cancer (GC) remains a significant global health challenge due to its high mortality and frequent resistance to chemotherapy drugs like cisplatin (DDP). Carnosic acid (CA), a phenolic diterpene, exhibits potential anti-cancer properties. This study aimed to investigate the role of CA in regulating GC development and DDP sensitivity. Methods: The half-maximal inhibitory concentration (IC50) of DDP and cell viability were determined using a cell counting kit-8 assay. Cell proliferation was evaluated by a 5-Ethynyl-2’-deoxyuridine assay, while cell migration was assessed by a transwell assay. Cell death was analyzed through flow cytometry, fluorometric assay, and colorimetric assays. The targets of CA were identified using network pharmacology. Western blotting was employed to detect the protein expression of tumor protein p53 (TP53), solute carrier family 7 member 11 (SLC7A11), and arachidonate 12-lipoxygenase, 12 S type (ALOX12). Results: CA treatment significantly inhibited GC cell proliferation and migration and enhanced cell death. The treatment also elevated reactive oxygen species (ROS) and Fe2+ levels, while reducing glutathione (GSH) levels and the IC50 value for DDP in GC cells. In addition, TP53 was identified as a target of CA, and its protein expression was upregulated by CA treatment in GC cells. Silencing TP53 attenuated the effects of CA on cell proliferation, migration, death, and the sensitivity of tumor cells to DDP. Further, CA regulated the TP53-mediated SLC7A11/ALOX12 pathway. Conclusion: CA improved the sensitivity of GC cells to DDP and inhibited their malignant progression by regulating the TP53-mediated SLC7A11/ALOX12 axis, highlighting its potential clinical significance for GC treatment.Keywords
Funding Information
- Changzhou Science and Technology Bureau applied basic research guidance project (CJ20242039, CJ20242039, CJ20242039)
This publication has 34 references indexed in Scilit:
- Guiqi Baizhu decoction enhances radiosensitivity in non-small cell lung cancer by inhibiting the HIF-1α/DNA-PKcs axis-mediated DNA repairPhytomedicine, 2025
- Yanghe decoction inhibits inflammation-induced lung metastasis of colorectal cancerJournal of Ethnopharmacology, 2024
- Network pharmacology, molecular docking and biological verification to explore the potential anti-prostate cancer mechanisms of Tripterygium wilfordii Hook. FJournal of Ethnopharmacology, 2024
- Helicobacter pylori infection facilitates cell migration and potentially impact clinical outcomes in gastric cancerHeliyon, 2024
- Carnosic acid: an effective phenolic diterpenoid for prevention and management of cancers via targeting multiple signaling pathwaysPharmacological Research, 2024
- Cancer treatments: Past, present, and futureCancer Genetics, 2024
- Mechanism of cisplatin resistance in gastric cancer and associated microRNAsCancer Chemotherapy and Pharmacology, 2023
- The EEF1AKMT3/MAP2K7/TP53 axis suppresses tumor invasiveness and metastasis in gastric cancerCancer Letters, 2022
- Induction of ferroptosis by carnosic acid-mediated inactivation of Nrf2/HO-1 potentiates cisplatin responsiveness in OSCC cellsMolecular and Cellular Probes, 2022
- Molecular Mechanism of Helicobacter pylori-Induced Gastric CancerJournal of Gastrointestinal Cancer, 2020